Héron A, Bourguignon J, Callé A, Borghi H, Sesboüé R, Diarra-Mehrpour M, Martin J P
INSERM Unité 295, Faculté de Médecine-Pharmacie de Rouen, St. Etienne Rouvray, France.
Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):573-80. doi: 10.1042/bj3020573.
In human hepatoma HepG2 cells, the serum inter-alpha-trypsin inhibitor (ITI)-like protein is synthesized from two protein precursors, the heavy chain (H) H2 and the light chain (L). Both of them carry sulphate groups involved in the chondroitin sulphate glycosaminoglycan (GAG) linkage, as demonstrated by [35S]sulphate labelling, chondroitinase digestion and inhibition with beta-D-xyloside, an artificial GAG acceptor. While inhibition of N-glycosylation prevented neither the maturation nor the secretion of the ITI-related entities, brefeldin A induced the accumulation of H and L precursors in the cells, therefore blocking subsequent association and maturation of the precursors before their secretion. The enzyme system involved in the ester linkage between H and L chains is localized in the trans-Golgi network since no ITI-like protein could be obtained in the presence of monensin; instead free heavy-chain protein forms and bikunin were secreted in culture supernatants. The ITI-like protein synthesized by HepG2 cells is therefore composed of two heavy chains HC2 linked to two bikunin chains by chondroitin sulphate bridges, although the GAG linkage between HC2 chains is presumably different. Further, a different maturation route leading to restricted heavy-chain forms, Hm and Hd, could be shown.
在人肝癌HepG2细胞中,血清类间α-胰蛋白酶抑制剂(ITI)样蛋白由两种蛋白质前体合成,即重链(H)H2和轻链(L)。如[35S]硫酸盐标记、软骨素酶消化以及用人工GAG受体β-D-木糖苷抑制所证明的,它们都带有参与硫酸软骨素糖胺聚糖(GAG)连接的硫酸基团。虽然抑制N-糖基化既不阻止ITI相关实体的成熟也不阻止其分泌,但布雷菲德菌素A诱导细胞中H和L前体的积累,从而在其分泌之前阻断前体随后的缔合和成熟。参与H链和L链之间酯键连接的酶系统定位于反式高尔基体网络,因为在莫能菌素存在的情况下无法获得ITI样蛋白;相反,游离的重链蛋白形式和比库宁分泌到培养上清液中。因此,HepG2细胞合成的ITI样蛋白由两条通过硫酸软骨素桥与两条比库宁链相连的重链HC2组成,尽管HC2链之间的GAG连接可能不同。此外,可以显示出导致受限重链形式Hm和Hd的不同成熟途径。